$PETV

A.L. Sarroff Fund, LLC purchased $15K of PETV (indirect holdings)

A.L. Sarroff Fund, LLC purchased 22,740 indirectly-held shares of PetVivo Holdings, Inc. (PETV) at an average of $0.68 ($0.68–$0.69) across 2 trades over 2026-08-27 to 2026-09-09.

Original reporting
SEC EDGAR · A.L. Sarroff Fund, LLC
Published Sep 15, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PETV
Neutral
medium confidence
Mentioned
$PETV
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PETVNeutralLow
01

Why it matters

The transaction is modest in dollar terms and unlikely to move the stock significantly, but it adds a data point for monitoring insider sentiment.

02

Market read

Insider activity provides a small signal for traders; overall relevance is low.

03

What to watch

Potential upcoming clinical data or partnership announcements not disclosed in the filing.

Relevance 3/10Novelty 4/10Timing: post-filing today

Background

PetVivo Holdings, Inc. (PETV) is a microcap biotech company. The filing reports an insider purchase by a fund holding a 10% stake.

Company-level read

Ticker impact

$PETVNeutralMedium confidence
Context

Form 4 filing shows A.L. Sarroff Fund, LLC purchased 22,740 shares of PetVivo Holdings, increasing its stake to over 10 million shares.

Expected impact

Minor upward pressure, likely muted due to small transaction size.

Evidence & confidence

The $15K purchase by a 10% owner is a routine insider buy; market may view positively but impact is limited.

Market effects

PetVivo operates in the biotech/health sector; insider buy may slightly boost sector sentiment.

No significant regional effect.

Limited to investors tracking microcap biotech stocks.

Counterpoint

The purchase could be a strategic move to support share price ahead of upcoming financing, but may not signal long-term upside.

Key entities

  • PetVivo Holdings, Inc.

    Issuer of the Form 4 filing.

  • A.L. Sarroff Fund, LLC

    Purchaser and 10% owner of PETV.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PETVMedAI 8/10

PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform

PetVivo Holdings (OTCQX: PETV) said it agreed to acquire PiezoBioMembrane (PBM) via a merger, with PBM becoming a wholly owned subsidiary of Cosmeta Corp. PetVivo will issue 3,000,000 shares to PBM shareholders, with some consideration tied to milestones. The company expects PBM’s functional biomaterials and piezoelectric tech to expand IP and product development; closing is subject to customary conditions.